Randomized Controled Trial: Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Chemotherapy

Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study) – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentaries: Thalidomide Improves Prevention of Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy – PracticeUpdate (free registration required) AND Adding Thalidomide to Palonosetron, Dexamethasone Reduces CINV – Oncology Nurse Advisor (free)